Literature DB >> 30175394

Musculoskeletal Metastasis from Primary Rectal Cancer: Series of Two Cases of a Very Rare Occurrence with a Short Literature Review.

Sankalp Singh1, Niharika Bisht2, Richa Joshi2, Prabha Shankar Mishra2, Deepak Mulajker2, Samir Gupta2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30175394     DOI: 10.1007/s12029-018-0165-5

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  26 in total

1.  Bone metastasis from colonic carcinoma. A case report.

Authors:  P M Ihle; A A McBeath
Journal:  J Bone Joint Surg Am       Date:  1973-03       Impact factor: 5.284

2.  Oligometastases.

Authors:  S Hellman; R R Weichselbaum
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

3.  Occult carcinoma of the colon and rectum manifesting as osseous metastasis.

Authors:  J L Hoehn; J L Ousley; C S Avecilla
Journal:  Dis Colon Rectum       Date:  1979-03       Impact factor: 4.585

4.  [Intramuscular extremity metastasis of adenocarcinoma of the colon].

Authors:  H H Homan; T Mühlberger; C Kuhnen; H U Steinau
Journal:  Chirurg       Date:  2000-11       Impact factor: 0.955

5.  The tumor microenvironment as a determinant of drug response and resistance.

Authors:  William S. Dalton
Journal:  Drug Resist Updat       Date:  1999-10       Impact factor: 18.500

6.  Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancer.

Authors:  Muhammad A Khattak; Hilary L Martin; Carol Beeke; Timothy Price; Scott Carruthers; Susan Kim; Robert Padbury; Christos S Karapetis
Journal:  Clin Colorectal Cancer       Date:  2012-07-03       Impact factor: 4.481

7.  [Exophthalmos secondary to a lateral rectus muscle metastasis].

Authors:  C Burgueño Montañés; R López Roger
Journal:  Arch Soc Esp Oftalmol       Date:  2002-09

8.  FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

Authors:  Christophe Tournigand; Thierry André; Emmanuel Achille; Gérard Lledo; Michel Flesh; Dominique Mery-Mignard; Emmanuel Quinaux; Corinne Couteau; Marc Buyse; Gérard Ganem; Bruno Landi; Philippe Colin; Christophe Louvet; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2003-12-02       Impact factor: 44.544

9.  Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.

Authors:  Axel Grothey; Daniel Sargent; Richard M Goldberg; Hans-Joachim Schmoll
Journal:  J Clin Oncol       Date:  2004-04-01       Impact factor: 44.544

10.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.